Notable approvals
Breztri (budesonide/formoterol/glycopyrrolate inhaled) - New triple-combination aerosol inhaler approved for chronic obstructive pulmonary disease
Trelegy Ellipta (umeclidinium bromide/vilanterol inhaled/fluticasone furoate inhaled) - New indication for maintenance treatment of asthma
Bronchitol (mannitol inhalation) - New indication and brand for adults with cystic fibrosis as add-on maintenance therapy
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: FDA Approvals, Highlights, and Summaries: Pulmonology - Medscape - Feb 24, 2021.
Comments